105 related articles for article (PubMed ID: 435334)
21. [Spectroscopic and chromatographic studies on photochemical isomerism of alpha, beta-diunsaturated ketones].
Schleuder M; Am Ali F; Otto HH
Pharmazie; 2003 May; 58(5):308-11. PubMed ID: 12785314
[TBL] [Abstract][Full Text] [Related]
22. Quantitative dexamethasone and dexamethasone sodium phosphate determinations in pharmaceutical dosage forms by high-pressure liquid chromatography.
Gupta VD
J Pharm Sci; 1979 Jul; 68(7):926-8. PubMed ID: 458620
[TBL] [Abstract][Full Text] [Related]
23. Analysis of betamethasone, dexamethasone and related compounds by liquid chromatography/electrospray mass spectrometry.
Arthur KE; Wolff JC; Carrier DJ
Rapid Commun Mass Spectrom; 2004; 18(6):678-84. PubMed ID: 15052579
[TBL] [Abstract][Full Text] [Related]
24. The case of the tainted dexamethasone.
Eckerlin RH; Ebel JG; Henion JD; Covey TR
Anal Chem; 1989 Jan; 61(1):53A-59A. PubMed ID: 2653104
[No Abstract] [Full Text] [Related]
25. Development and validation of a stability-indicating RP-HPLC method to separate low levels of dexamethasone and other related compounds from betamethasone.
Xiong Y; Xiao KP; Rustum AM
J Pharm Biomed Anal; 2009 Apr; 49(3):646-54. PubMed ID: 19171447
[TBL] [Abstract][Full Text] [Related]
26. Thin-layer chromatographic detection of glucocorticoids.
Wu SM; Chen SH; Wu HL
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Nov; 7(11):545-9. PubMed ID: 1766024
[TBL] [Abstract][Full Text] [Related]
27. High-performance liquid chromatographic determination of epimers, impurities, and content of the glucocorticoid budesonide and preparation of primary standard.
Roth G; Wikby A; Nilsson L; Thalén A
J Pharm Sci; 1980 Jul; 69(7):766-70. PubMed ID: 7391935
[TBL] [Abstract][Full Text] [Related]
28. Intraocular fate of dexamethasone disodium phosphate topically applied to the eyes of rabbits.
Ichigashira N; Yamaga N
Steroids; 1978 Dec; 32(5):615-28. PubMed ID: 734696
[TBL] [Abstract][Full Text] [Related]
29. Separation and characterization of allergenic polymerized impurities from cephalosporin for injection by trap free two-dimensional high performance size exclusion chromatography × reversed phase liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
Xu Y; Wang D; Zhu B; Tang L; Wang J
J Pharm Biomed Anal; 2018 May; 154():425-432. PubMed ID: 29579634
[TBL] [Abstract][Full Text] [Related]
30. Quantitative impurity profiling by principal component analysis of high-performance liquid chromatography-diode array detection data.
Wiberg K
J Chromatogr A; 2006 Mar; 1108(1):50-67. PubMed ID: 16430906
[TBL] [Abstract][Full Text] [Related]
31. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
Xiang TX; Niemi R; Bummer P; Anderson BD
J Pharm Sci; 2003 Oct; 92(10):2027-39. PubMed ID: 14502542
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a HPLC method for 4,7-phenanthroline-5,6-dione I and identification of its major impurity by HPLC-MS-APCI.
Shabir GA; Forrow NJ
J Chromatogr Sci; 2005 Apr; 43(4):207-12. PubMed ID: 15975237
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of trace betamethasone or dexamethasone in dexamethasone or betamethasone active pharmaceutical ingredients by reversed-phase high-performance liquid chromatography.
Xiao KP; Xiong Y; Rustum AM
J Chromatogr Sci; 2008 Jan; 46(1):15-22. PubMed ID: 18218183
[TBL] [Abstract][Full Text] [Related]
34. Crystallization-induced dynamic resolution R-epimer from 25-OCH3-PPD epimeric mixture.
Zhang S; Tang Y; Cao J; Zhao C; Zhao Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Nov; 1005():39-46. PubMed ID: 26491820
[TBL] [Abstract][Full Text] [Related]
35. LC determination of glimepiride and its related impurities.
Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
[TBL] [Abstract][Full Text] [Related]
36. Determination of gallamine and its impurities by reversed-phase ion-pair high-performance liquid chromatography and comparison with thin-layer chromatography.
Mourier PA
J Chromatogr; 1989 Jan; 462():281-92. PubMed ID: 2738125
[TBL] [Abstract][Full Text] [Related]
37. Determination of tropicamide and its major impurity in raw material by the HPLC-DAD analysis and identification of this impurity using the off-line HPLC-FT-IR coupling.
Stefanowicz Z; Stefanowicz J; Mulas K
J Pharm Biomed Anal; 2009 Feb; 49(2):214-20. PubMed ID: 19062216
[TBL] [Abstract][Full Text] [Related]
38. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B
J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563
[TBL] [Abstract][Full Text] [Related]
39. Identification of isomers and subsidiary colors in commercial Fast Green FCF (FD&C Green No. 3, Food Green No. 3) by liquid chromatography-mass spectrometry and comparison between amounts of the subsidiary colors by high-performance liquid chromatography and thin-layer chromatography-spectrophotometry.
Tsuji S; Yoshii K; Tonogai Y
J Chromatogr A; 2006 Jan; 1101(1-2):214-21. PubMed ID: 16246352
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone phosphate stability and contamination of solutions stored in syringes.
Lau DW; Law S; Walker SE; Iazzetta J
PDA J Pharm Sci Technol; 1996; 50(4):261-7. PubMed ID: 8810842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
